Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

ClinicalTrials.gov ID: NCT01266447

Public ClinicalTrials.gov record NCT01266447. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 12:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of ABT-888 (NCI Supplied Agent: ABT-888, NSC #737664), Topotecan (NSC # 609699) and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Squamous or Non-squamous Cell Carcinoma of the Cervix

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II clinical trial is studying the how well veliparib, topotecan hydrochloride, and filgrastim or pegfilgrastim work in treating patients with persistent or recurrent cervical cancer. Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as topotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by blocking them from dividing. Giving veliparib with chemotherapy may kill more tumor cells. Filgrastim or pegfilgrastim may cause the body to make more blood cells and help it recover from the side effects of chemotherapy.

Study identification

NCT ID
NCT01266447
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
27 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2011
Primary completion
Dec 31, 2015
Completion
Dec 31, 2015
Last update posted
Aug 7, 2019

2011 – 2016

United States locations

U.S. sites
78
U.S. states
25
U.S. cities
59
Facility City State ZIP Site status
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868
University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora Colorado 80045
Smilow Cancer Hospital Care Center at Saint Francis Hartford Connecticut 06105
The Hospital of Central Connecticut New Britain Connecticut 06050
Florida Hospital Orlando Orlando Florida 32803
Memorial University Medical Center Savannah Georgia 31404
Saint Alphonsus Cancer Care Center-Boise Boise Idaho 83706
Decatur Memorial Hospital Decatur Illinois 62526
Sudarshan K Sharma MD Limted-Gynecologic Oncology Hinsdale Illinois 60521
Memorial Medical Center Springfield Illinois 62781
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287
Saint Joseph Mercy Hospital Ann Arbor Michigan 48106-0995
Michigan Cancer Research Consortium CCOP Ann Arbor Michigan 48106
Oakwood Hospital and Medical Center Dearborn Michigan 48124
Saint John Hospital and Medical Center Detroit Michigan 48236
Hurley Medical Center Flint Michigan 48502
Genesys Regional Medical Center Grand Blanc Michigan 48439
Allegiance Health Jackson Michigan 49201
Borgess Medical Center Kalamazoo Michigan 49001
Bronson Methodist Hospital Kalamazoo Michigan 49007
West Michigan Cancer Center Kalamazoo Michigan 49007
Sparrow Hospital Lansing Michigan 48912
Saint Mary Mercy Hospital Livonia Michigan 48154
Saint Joseph Mercy Oakland Pontiac Michigan 48341
Saint Joseph Mercy Port Huron Port Huron Michigan 48060
Saint Mary's of Michigan Saginaw Michigan 48601
University of Mississippi Medical Center Jackson Mississippi 39216
Cancer Research for the Ozarks NCORP Springfield Missouri 65804
Mercy Hospital Springfield Springfield Missouri 65804
CoxHealth South Hospital Springfield Missouri 65807
Women's Cancer Center of Nevada Las Vegas Nevada 89169
Cooper Hospital University Medical Center Camden New Jersey 08103
Southwest Gynecologic Oncology Associates Inc Albuquerque New Mexico 87106
University of New Mexico Cancer Center Albuquerque New Mexico 87106
State University of New York Downstate Medical Center Brooklyn New York 11203
North Shore University Hospital Manhasset New York 11030
Long Island Jewish Medical Center New Hyde Park New York 11040
North Shore-LIJ Health System/Center for Advanced Medicine New Hyde Park New York 11040
Case Western Reserve University Cleveland Ohio 44106
Riverside Methodist Hospital Columbus Ohio 43214
Lake University Ireland Cancer Center Mentor Ohio 44060
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa Oklahoma 74146
Abington Memorial Hospital Abington Pennsylvania 19001
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Women and Infants Hospital Providence Rhode Island 02905
University Medical Center Brackenridge Austin Texas 78701
Parkland Memorial Hospital Dallas Texas 75235
Zale Lipshy University Hospital Dallas Texas 75235
Clements University Hospital Dallas Texas 75390
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390
Scott and White Memorial Hospital Temple Texas 76508
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298
PeaceHealth Medical Group PC Bellingham Washington 98226
Harrison HealthPartners Hematology and Oncology-Bremerton Bremerton Washington 98310
Harrison Medical Center Bremerton Washington 98310
Providence Regional Cancer Partnership Everett Washington 98201
Skagit Valley Hospital Regional Cancer Care Center Mount Vernon Washington 98273
Harrison HealthPartners Hematology and Oncology-Poulsbo Poulsbo Washington 98370
Pacific Gynecology Specialists Seattle Washington 98104
Fred Hutchinson Cancer Research Center Seattle Washington 98109
Seattle Cancer Care Alliance Seattle Washington 98109
Group Health Cooperative-Seattle Seattle Washington 98112
Swedish Medical Center-First Hill Seattle Washington 98122-4307
Northwest Hospital Seattle Washington 98133
University of Washington Medical Center Seattle Washington 98195
Olympic Medical Cancer Care Center Sequim Washington 98384
Cancer Care Northwest - Spokane South Spokane Washington 99202
Rockwood Cancer Treatment Center-DHEC-Downtown Spokane Washington 99204
MultiCare Tacoma General Hospital Tacoma Washington 98405
Saint Joseph Medical Center Tacoma Washington 98405
Providence Saint Mary Regional Cancer Center Walla Walla Washington 99362
Wenatchee Valley Hospital and Clinics Wenatchee Washington 98801
D N Greenwald Center Mukwonago Wisconsin 53149
Oconomowoc Memorial Hospital-ProHealth Care Inc Oconomowoc Wisconsin 53066
Waukesha Memorial Hospital Waukesha Wisconsin 53188

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01266447, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 7, 2019 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01266447 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →